Gastro-oesophageal reflux in children.
Kumar
Yadlapalli
Y
Consultant Paediatrician Royal Cornwall Hospital, Treliske Truro Cornwall, UK.
Sarvananthan
Rajini
R
D000464:Alginates / Q000008:administration & dosage / Q000009:adverse effects; D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use; D020117:Cisapride / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D018662:Fundoplication; D005764:Gastroesophageal Reflux / Q000209:etiology / Q000628:therapy*; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D006635:Histamine H2 Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007223:Infant; D007225:Infant Food; D016684:Prone Position; D054328:Proton Pump Inhibitors; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000464:Alginates; D000897:Anti-Ulcer Agents; D006603:Hexuronic Acids; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D020723:Glucuronic Acid; D020117:Cisapride